Bimuno® GOS

Galacto-oligosaccharides (GOS)

Bimuno® GOS is a patented prebiotic ingredient based on non-digestible galacto-oligosaccharides (GOS), selected and distributed exclusively for the Italian market by Pharmanutra Ingredients.
Recognised as one of the most extensively researched GOS ingredients internationally, BIMUNO® is characterised by a specific molecular structure that enables a targeted prebiotic action at low dosages, with superior stability and versatility of application.

Ingredient characteristics

Bimuno® GOS is available in powder and syrup and consists of a unique mixture of non-digestible galacto-oligosaccharides (GOS) with specific β-linkages, including 3′-galactosyl-lactose, a structure similar to components found in human milk oligosaccharides (HMOs). Being non-digestible in the upper gastrointestinal tract, BIMUNO® reaches the colon intact, where it is selectively fermented by beneficial bacteria such as bifidobacteria and lactobacilli.
Its distinctive structure underlies the documented bifidogenic activity observed in clinical studies even at low dosages.

Formulation stability and versatility

BIMUNO® GOS stands out for:

  • high thermal and pH stability
  • microbiological stability
  • excellent tolerability
  • good solubility
  • neutral flavour

These characteristics make it suitable for a wide range of applications, including high-quality gut wellness products and formulations undergoing complex industrial processes.

Exclusive distribution for Italy

Pharmanutra Ingredients distributes Bimuno® exclusively for the Italian market, offering customers:

  • complete technical documentation
  • regulatory support
  • dedicated formulation assistance

Data sheet, safety data sheet (SDS) and technical documentation available upon request

Scientific profile and rationale for use

BIMUNO® GOS is supported by over 130 scientific publications and 25 clinical studies, which have examined its role in the gut microbiota and the mechanisms of interaction between the intestine and other physiological systems.
The nutritional interest in BIMUNO® focuses in particular on:

  • selective modulation of the gut microbiota
  • support of gastrointestinal balance
  • gut–brain axis interactions
  • applications in immunonutrition

The prebiotic effect was already observed within 7 days of use in controlled studies, with efficacy demonstrated at doses as low as 380 mg/day.

  • Supported by over 130 publications and 25 clinical studies
  • Over 90 specific claims for foreign markets
  • Effective at very low doses (380 mg/day)
  • Prebiotic effect demonstrated in 7 days
  • High stability
  • GRAS-certified
  • Non-GMO
  • Gluten-free
  • Vegetarian
  • Halal and Kosher certified

  • Sports nutrition
  • Nutraceuticals
  • Infant nutrition
  • Functional foods
  • Synbiotic products
Digestion Digestion
Sports nutrition Sports nutrition
Immune system Immune system